Review article · 20 Dec 2016
Conference abstractPublished 5 Jul 2013
Obesity and dementia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anthropometric measures of obesity, such as Body Mass Index (BMI) and waist circumference or waist-to-hip ratio (WHR) are linked to clinical dementia and Alzheimer?s Disease (AD) in epidemiological studies. Overweight and obesity, measured as BMI or WHR, in mid- and late-life may increase risk for dementia, whereas decline in body weight or BMI, and subsequent underweight in the years preceding and at the time of dementia diagnosis may relate to dementia. The role of adipose tissue during these periods of life in relation to later and concurrent risk for cognitive decline and dementia is not understood. Biological mechanisms linking adipose tissue to the aging brain and neurocognitive symptoms may be related to interactions between peripheral and central metabolism. Hypotheses relating adipose tissue to cognitive decline and dementia may relate to the peripheral and cerebral vasculature; actions of adipose tissue hormones (adipokines), such as leptin and adiponectin, and adipose tissue-related hormones, such as ghrelin, on brain regions that are important for neurocognition; adipose tissue effects on energy metabolism; change in adipose tissue morphology over time; and genetic susceptibility based on the identification of genes important for both adipose tissue and the brain. Given the ubiquity of adipose tissue and its multi-functionality, metabolic implications over the life course on health of the aging brain and dementia risk are great. The purpose of this presentation is to overview the epidemiology of anthropometric measures and dementia, and to discuss potential underlying mechanisms of action whereby adipose tissue influences neurocognitive processes in the brain.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 22 Nov 2022
Leptin's Role in Obesity as a Dementia and Alzheimer's Disease Risk Factor
Conference abstract · 7 Sep 2018
Do older adults obesity and overweight prevent dementia risk?: A new population-based cohort study from China
Commentary · 31 Dec 2015
Medicinal Property of Sage (Saliva) for Curing Illnesses Such as Obesity, Diabetes, Depression, Dementia, Lupus, Autism, Heart Disease and Cancer: A Brief Review
Conference abstract · 2018
Serum levels of high molecular weight adiponectin and leptin in elderly patients with dementia
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Mini review · 13 Apr 2026
Semaglutide in the Real World: Bridging Effectiveness and Clinical Feasibility Through Flexible Dose Titration
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Deborah R. Gustafson”
